Valeant Pharmaceuticals - PDFSEARCH.IO - Document Search Engine

Valeant Pharmaceuticals
Results: 93

#	Item
41	Conference 2013 Exhibitor List Allergan Inc. Amgen Canada Apotex Inc AstraZeneca Auro Pharma Add to Reading List Source URL: opacossette.associationserver.com Language: English - Date: 2013-10-02 11:09:14 Pfizer Pharmacist Leslie Dan Pharmaceutical industry in Bangladesh Valeant Pharmaceuticals Canada Pharmaceutical sciences Companies listed on the New York Stock Exchange Medicinal chemistry Pharmacy
42	Incorporation number: C0977395 VALEANT PHARMACEUTICALS INTERNATIONAL, INC. (the “Company”) The Company has as its articles the following articles. Add to Reading List Source URL: www.valeant.com Language: English - Date: 2013-09-18 14:32:45 Law Stock market Types of business entity Business law Securities Stock certificate Corporation Dividend Board of directors Corporations law Business Private law
43	1 2 UNITED STATES DISTRICT COURT 3 Add to Reading List Source URL: www.cacd.uscourts.gov Language: English - Date: 2014-11-04 12:17:07 J. Michael Pearson Bill Ackman Pershing Square Capital Management Tender offer Takeover Business Finance Financial economics Corporate finance Allergan Valeant Pharmaceuticals
44	HEALTHCARE COMPLIANCE POLICY Effective Date: May 20, 2013 Version: 3 Policy No.: VRX-US-CMP-001 Approved by: VP, Chief Compliance Officer and Add to Reading List Source URL: www.valeant.com Language: English - Date: 2014-04-23 14:54:54 Companies listed on the New York Stock Exchange Valeant Pharmaceuticals Pharmaceutical industry Pharmaceutical Research and Manufacturers of America Chief compliance officer Compliance training American Medical Association Pharmacology Pharmaceutical sciences Corporate governance Regulatory compliance
45	Case 8:14-cv[removed]DOC-AN Document[removed]Filed[removed]Page 1 of 81 Page ID #:7340 EXHIBIT 1 Exhibit 1 - Page 15 Add to Reading List Source URL: blogs.reuters.com Language: English - Date: 2014-10-24 18:02:59 Q Pershing Square Capital Management Star Trek Investment Finance Bill Ackman Valeant Pharmaceuticals Q source
46	US Medical and Continuing Medical Education Grant Funding Report: First Quarter[removed]includes Medicis, a division of Valeant Pharmaceuticals) Recipient Name Derm Research, PLLC Add to Reading List Source URL: www.valeant.com Language: English - Date: 2013-05-02 10:58:56 Restylane American Academy of Dermatology Botulinum toxin Medicine Companies listed on the New York Stock Exchange Valeant Pharmaceuticals
47	VALEANT PHARMACEUTICALS INTERNATIONAL, INC. CORPORATE GOVERNANCE GUIDELINES August 21, [removed]BOARD RESPONSIBILITIES Add to Reading List Source URL: www.valeant.com Language: English - Date: 2014-09-03 09:08:48 Committees Private law Management Law Board of directors Business law Non-executive director Valeant Pharmaceuticals Audit committee Corporations law Corporate governance Business
48	Valeant Pharmaceuticals International, Inc. POLICY NO. H.R. – Sec. 9 – 914 Add to Reading List Source URL: www.valeant.com Language: English - Date: 2013-11-07 10:01:05 United States corporate law United States securities law Finance Risk Applied ethics Sarbanes–Oxley Act Audit U.S. Securities and Exchange Commission Business ethics Auditing Corporate governance Business
49	VALEANT PHARMACEUTICALS INTERNATIONAL, INC. CHARTER OF THE AUDIT AND RISK COMMITTEE 1. PURPOSE Add to Reading List Source URL: www.valeant.com Language: English - Date: 2014-09-03 09:35:25 Risk Audit committee Internal audit Audit Internal control Statements on Auditing Standards Corporate governance Chief audit executive External auditor Auditing Accountancy Business
50	VALEANT PHARMACEUTICALS INTERNATIONAL, INC. CHARTER OF THE NOMINATING AND CORPORATE GOVERNANCE COMMITTEE 1. PURPOSE Add to Reading List Source URL: www.valeant.com Language: English - Date: 2014-09-03 10:37:40 Business Management Private law Structure Auditing Board of directors Audit committee National Association of Corporate Directors Committees Corporations law Corporate governance